Yaupon Therapeutics Closes $4 mln Financing
13th Nov 2006, 17:24 GMT
Series B financing positions company to advance development of its product portfolio targeting cancer and central nervous system diseases
Yaupon Therapeutics Closes $4 mln Financing related news:
- Cerenis Therapeutics Closes $53.5 mln Financing — Cardiology News from StratCenter.com
- Pharmaceutical firm gets venture funding — Latest news from Philadelphia Business Journal
- Tacere Therapeutics Appoints VP, R&D — Pharmaceuticals News from StratCenter.com
- Tacere Therapeutics Appoints Vice President, Research and Development — RedOrbit News - Health
- Repros Therapeutics 3Q Loss Widens — Financial News News from StratCenter.com
- Radial Energy Announces Receipt of $1,500,000 — Partnerships/ Joint Ventures News from StratCenter.com
- Glass Earth Closes NZ$10 Million Financing and Starts New Exploration Season — ArriveNet : Business
- CHAD Therapeutics revenue down, loss up in 2Q — Latest news from Los Angeles Business from bizjournals
- Chelsea Therapeutics Reports Third Quarter 2006 Results — ArriveNet : Press Releases
- Targacept narrows 3Q loss — Bio-Technology News from StratCenter.com
Latest news from Partnerships/ Joint Ventures News from StratCenter.com:
- Local firm forms foundation for women's sexual health
- Lifeline Therapeutics to Recognize Previously Deferred Retail Chain Revenue
- Interim Data on Use of tgAAC94 in the Treatment of Inflammatory Arthritis Presented at the American College of Rheumatology Meeting
- NextGen Healthcare and Primetime Medical Software Partner to Enhance Communications Between Doctors and Patients
- 3 Keane Executives to Present at the 2006 Gartner Healthcare Summit in San Diego
- CareTech Solutions and Yampa Valley Med Cntr Announce New IT Outsourcing Agreement
- Genelabs Technologies Reports Financial Results for Q3 and 1st 9 Months of 2006
- Frost & Sullivan Honors Covance for Superior Market Leadership, Creating Enhanced Customer Value in the North American CRO Market
- Health Care Property Closes $1B Offering
- - Webcast Alert: Isis Pharmaceuticals Announces Its Analyst/Investor Webcast Presentation